Therapeutic Potential of Myrtenal and Its Derivatives—A Review
Life · 20.10.2023 · 13 (10) · 2086
DOI: 10.3390/life13102086 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Life, online erschienen am 20.10.2023. Verfasst von Stela Dragomanova und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology, Toxicology and Pharmacotherapy, Faculty of Pharmacy, Medical University of Varna, 84 A Tsar Osvoboditel Blvd., 9002 Varna…. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 164 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
The investigation of monoterpenes as natural products has gained significant attention in the search for new pharmacological agents due to their ability to exhibit a wide range in biological activities, including antifungal, antibacterial, antioxidant, anticancer, antispasmodic, hypotensive, and vasodilating properties. In vitro and in vivo studies reveal their antidepressant, anxiolytic, and memory-enhancing effects in experimental dementia and Parkinson’s disease. Chemical modification of natural substances by conjugation with various synthetic components is a modern method of obtaining new biologically active compounds. The discovery of new potential drugs among monoterpene derivatives is a progressive avenue within experimental pharmacology, offering a promising approach for the therapy of diverse pathological conditions. Biologically active substances such as monoterpenes, for example, borneol, camphor, geraniol, pinene, and thymol, are used to synthesize compounds with analgesic, anti-inflammatory, anticonvulsive, antidepressant, anti-Alzheimer’s, antiparkinsonian, antiviral and antibacterial (antituberculosis) properties. Myrtenal is a perspective monoterpenoid with therapeutic potential in various fields of medicine. Its chemical modifications often lead to new or more pronounced biological effects. As an example, the conjugation of myrtenal with the established pharmacophore adamantane enables the augmentation of several of its pivotal properties. Myrtenal–adamantane derivatives exhibited a variety of beneficial characteristics, such as antimicrobial, antifungal, antiviral, anticancer, anxiolytic, and neuroprotective properties, which are worth examining in more detail and at length.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology, Toxicology and Pharmacotherapy, Faculty of Pharmacy, Medical University of Varna, 84 A Tsar Osvoboditel Blvd., 9002 Varna, Bulgaria.
- Department of Pharmaceutical Technologies, Faculty of Pharmacy, Medical University of Varna, 84 A Tsar Osvoboditel Blvd., 9002 Varna, Bulgaria.
- Department of Medicinal Chemistry, Novosibirsk Institute of Organic Chemistry of the Russian Academy of Sciences, 9 Lavrentiev Av., 630090 Novosibirsk, Russia.
- Institute of Neurobiology, Bulgarian Academy of Sciences, Acad. G. Bonchev St., Block 23, 1113 Sofia, Bulgaria.
- Department of Healthcare, South-West University, 66 Ivan Mihailov St., 2700 Blagoevgrad, Bulgaria.
ORCID-Profile: Stela Dragomanova, Velichka Andonova, Konstantin Volcho, Reni Kalfin
Zitieren
APA
Dragomanova, S., Andonova, V., Volcho, K., Salakhutdinov, N., Kalfin, R., & Tancheva, L. (2023). Therapeutic Potential of Myrtenal and Its Derivatives—A Review. Life, 13(10), 2086. https://doi.org/10.3390/life13102086
Vancouver
Dragomanova S, Andonova V, Volcho K, Salakhutdinov N, Kalfin R, Tancheva L. Therapeutic Potential of Myrtenal and Its Derivatives—A Review. Life. 2023;13(10):2086. doi:10.3390/life13102086
BibTeX
@article{Dragomanova2023,
author = {Dragomanova, Stela and Andonova, Velichka and Volcho, Konstantin and Salakhutdinov, Nariman and Kalfin, Reni and Tancheva, Lyubka},
title = {Therapeutic Potential of Myrtenal and Its Derivatives—A Review},
journal = {Life},
year = {2023},
volume = {13},
number = {10},
pages = {2086},
doi = {10.3390/life13102086}
}
EUVIMED